Because previous studies have identified TSLP, IL-25 and IL-33 as potent activators of innate lymphoid cells in allergic and non-allergic disease states [6, 7, 41], we chose to assess potential activation of lung ILC2 by these epithelium-derived cytokines. The gene discussed is IL33; the disease is allergic disease.